03.03.2014 Views

How to investigate levels of Adherence to antiretroviral ... - INRUD

How to investigate levels of Adherence to antiretroviral ... - INRUD

How to investigate levels of Adherence to antiretroviral ... - INRUD

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

APPENDIX 1 --- Frequently asked questions<br />

A.1<br />

1. Why is it necessary <strong>to</strong> measure adherence?<br />

Because <strong>of</strong> the ever present threats <strong>of</strong> treatment failure and resistance.<br />

2. What use will it be <strong>to</strong> have a standardized method <strong>of</strong> measurement?<br />

Standardization is needed so that rates can be compared over time and between facilities. A<br />

manager may know:<br />

<strong>How</strong> a facility is doing at that moment<br />

<strong>How</strong> it is doing over time<br />

<strong>How</strong> it compares <strong>to</strong> other facilities<br />

To assess the effectiveness <strong>of</strong> interventions <strong>to</strong> improve adherence <strong>levels</strong>.<br />

All <strong>of</strong> these indica<strong>to</strong>rs will, in turn, give a yardstick for managers <strong>to</strong> concentrate energies<br />

and resources on poorer performing facilities for maximal system strengthening.<br />

3. Why is more than one indica<strong>to</strong>r needed?<br />

The problem with measuring adherence <strong>to</strong> ARVs is that it is a behaviour that takes place in<br />

the privacy <strong>of</strong> the patient’s home. Therefore, all measures are indirect and subject <strong>to</strong><br />

different biases and inaccuracies. <strong>How</strong>ever all <strong>of</strong> these correlate with clinical outcome.<br />

4. <strong>How</strong> do we sample facilities?<br />

See Chapter 4, opening paragraph.<br />

5. <strong>How</strong> do we sample patient records?<br />

Use Figure 1 in Chapter 4.<br />

6. Which dates do we use for dispensing and patient attendance?<br />

Use Table 6 in Chapter 4.<br />

7. Who should we have permission from <strong>to</strong> do the survey?<br />

The National AIDS Control Programme and/or a local ethical review board.<br />

8. Who should I communicate with in the facilities?<br />

It is important <strong>to</strong> ask permission from the head <strong>of</strong> the facility and let the head <strong>of</strong> the facility<br />

and the head <strong>of</strong> the HIV/AIDS clinic know your intention. It is <strong>of</strong>ten useful <strong>to</strong> communicate<br />

with the pharmacist <strong>to</strong> ensure that you are planning your visit on a day when patients are<br />

expected.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!